U.S. Supreme Court Asked To Find That Off-Label Use Of Infuse Is Not Preempted
WASHINGTON, D.C. — An Infuse bone graft plaintiff on Sept. 11 asked the U.S. Supreme Court to decide if its medical device preemption precedents preempt claims involving the off-label use of...To view the full article, register now.
Already a subscriber? Click here to view full article